Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Novartis
Accenture
Fish and Richardson
Moodys
Colorcon
McKesson
Merck
US Army
Fuji

Generated: January 23, 2018

DrugPatentWatch Database Preview

SERZONE Drug Profile

« Back to Dashboard

When do Serzone patents expire, and what generic alternatives are available?

Serzone is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in SERZONE is nefazodone hydrochloride. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.

US Patents and Regulatory Information for SERZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-001 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-004 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-002 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-003 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-006 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb SERZONE nefazodone hydrochloride TABLET;ORAL 020152-005 Dec 22, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for SERZONE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Healthtrust
Baxter
Federal Trade Commission
Cantor Fitzgerald
Accenture
US Department of Justice
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot